Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help ...

Dr Richard Pazdur retired from leading the FDA’s Center for Drug Evaluation and Research amid internal disagreements over approval processes.

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Scientific advice by EMA. At different stages of your development process, you can go for scientific advice with the EMA. While this service is not free, the associated fees can vary, typically ...

Disc Medicine ( ($IRON) ) has shared an announcement. On December 7, 2025, Disc Medicine held a conference call to discuss its data presented at ...

Tekashi 6ix9ine already knows what he'll be up to after he serves his 3-month prison sentence next year ... because a judge ...

In October 2025, the FDA released a revised guidance titled, “Expanded Access to Investigational Drugs for Treatment Use—Questions and Answers.” ...

If the products were acquired through the Novo Nordisk Patient Assistance Program, the product is genuine and not counterfeit.

With the Technology-Enabled Meaningful Patient Outcomes initiative, some digital health developers will offer devices for ...

PureTech Health PLC (NASDAQ:PRTC) dropped 8.1% in Monday’s premarket trading after providing an update on its End-of-Phase 2 ...

With prescription drug costs on the rise, Texoma patients, along with local business owners, are feeling the pressure.